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Abstract 
Background : To compare  Immature Reticulocyte 
Fraction IRF) with Absolute Neutrophil Count 
(ANC) in post chemotherapy acute leukameia 
patients to assess marrow recovery. 
 Methods: In this comparative study, 45 diagnosed 
cases of AML and ALL on chemotherapy  for 
remission induction/consolidation, between age 
group of  2 - 60 years were included. Complete blood 
count (CBC) was done. Immature reticulocyte 
fraction was done by using automated hematology 
analyzer Sysmex XT 2000i.Absolute neutrophil count 
was calculated from total leukocyte count and 
differential count of white blood cells. True positive 
and true negative patients, showing recovery on the 
basis of IRF and ANC were calculated. Ch- square 
test was used. P-value <0.05 was considered 
statistically significant  
Results:   Age ranged from3-39years while the 
mean age was 15 ± 11 years . Nineteen (42%) patients 
were male and 26 (58%) patients were female. The 
mean recovery day for IRF was 11.7± 7.1, while that 
for ANC was 17.5 ± 9.32.Out of 45 patients, IRF 
predicted recovery in 41 patients and was unable to 
show recovery in 4 patients. Similarly ANC 
predicted recovery in 36 patients, but was unable to 
predict recovery in 9 patients. In 34 patients, both 
ANC and IRF showed recovery. So the True positive 
patients were 34 (75%). In these 34 patients, IRF was 
early predictor in 24 (70.5%) cases and ANC in 10 
(29.5%) cases. Similarly patients who had not shown 
recovery both by IRF and ANC were 4.So the True 
negative  patients were 4(8.8%). Patients who  were 
negative on IRF were 4. Similarly total patients 
positive on ANC were 36 and patients who were 
negative on ANC were 9. Patients showing recovery 
both by IRF and ANC were 34 out of 45. 
Conclusion: IRF can predict bone marrow recovery 
earlier than ANC count .IRF can serve as an 
additional parameter in patients who are in need of 
evaluation of bone marrow recovery after 
chemotherapy. 
Key Words: Acute leukemia, Immature 
Reticulocyte Fraction, IRF, Absolute Neutrophil 
Count, ANC,Bone marrow recovery.   
              
Introduction 
  Acute leukaemia is a malignant disorder in which 
neoplastic white cells arising from haemopoietic stem 
cell infiltrate blood and bone marrow.1 It has been 
shown that in 100,000 newly diagnosed cases of acute 
myeloid leukaemia  (AML) is about 2.5% and acute 
lymphoblastic leukaemia(ALL) is about 1.3%.2 A study 
has shown that among the malignant haematological 
disorders AML was common  (27.69%) followed by 
ALL (9.04%).3 Intensive chemotherapy is the treatment 
option which is available, that can be combined with 
stem cell transplantation. This treatment however is 
followed by a period of severe bone marrow failure in 
which patients have low blood counts.4This is the most 
critical period because of risk of infection and bleeding 
 in these patients. 
Reticulocytes are immature red cell. Reticulocyte count 
can be used to assess erythropoiesis or haematopoietic 
recovery after chemotherapy. Microscopic 
quantification of reticulocytes has now been replaced 
by automated flow cytometric counters.5 These 
counters can also measure immature reticulocyte 
fraction (IRF) which indicates the less mature 
reticulocytes population.6 Absolute neutrophil count 
(ANC) is used for monitoring chemotherapy and it has 
been shown that this parameter has sensitivity >96%. 
Present practice is to assess bone marrow recovery 
after chemotherapy through monitoring of absolute 
neutrophil count, but it has been shown that IRF is 
more reliable and can provide this information earlier. 
According to a study performed to assess bone 
marrow recovery after chemotherapy IRF did show 
early bone marrow recovery in 78% cases as compared 
to ANC.Another study has shown that IRF has a 
sensitivity of 97%.9 Haematology analyzers are now 
equipped to perform a reticulocyte count which has 
IRF as an important adjunct. IRF is now considered as 
an important parameter of clinical utility because its 
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increase occurs before an increase in total reticulocyte 
count and absolute neutrophil count, so it can be used 
to monitor bone marrow recovery after transplant or 
chemotherapy.10 
 
Patients and Methods  
 This comparative study was performed at 
Haematology department of Fauji Foundation 
Hospital, Rawalpindi,  from  February 2013 to  August 
2013. According to WHO sample size calculator, 
Calculations Confidence level was taken  
95%,anticipated population proportion was  taken 97% 
 and absolute precision required  was 8%. Sample size 
(n) was  approximately 40 patients.Diagnosed cases of 
AML and ALL on chemotherapy  for remission 
induction/consolidation , between age group of  2 - 60 
years were included. 
  Complete blood count (CBC) was done by using 
automated haematology analyzer Sysmex XT 2000i. 
Immature reticulocyte fraction was done by using 
automated haematology analyzer Sysmex XT 2000i. 
Determination of IRF by sysmex is a flow cytometry 
based technique. Sysmex XE 2100 uses patented 
polymethine fluorescent dye to stain RNA content of 
reticulocytes. Reticulocyte diffferential count which is 
done on this analyser is based on RNA content of the 
cell . Three fractions high fluorescence 
ratio(HFR),middle fluoresence ratio(MFR) and low 
fluorescence ratio(LFR) are determined. IRF is sum of 
HFR AND MFR. Absolute neutrophil count was 
calculated from total leukocyte count and differential 
count of white blood cells. Measurement technique 
bias was controlled by applying standardized 
laboratory test. Selection bias was controlled by 
applying inclusion and exclusion criteria. For 
quantitative variables like age, ANC, IRF mean ±SD 
was calculated. True positive and true negative 
patients, showing recovery on the basis of IRF and 
ANC were calculated. Ch- square test was used. P-
value <0.05 was considered statistically significant. For 
qualitative variables like gender and accuracy, 
frequency and percentage were calculated.  
 
Results 
 Age ranged from 3-39 years while the mean age was 
15 ± 11 years. Nineteen (42%) patients were male and 
26 (58%) patients were female. The mean recovery day 
for IRF was 11.7± 7.1, while that for ANC was 17.5 ± 
9.32 (Table 1).Out of 45 patients, IRF predicted 
recovery in 41 patients and was unable to show 
recovery in 4 patients. ANC predicted recovery in 36 
patients, but was unable to predict recovery in 9 
patients. In 34 patients, both ANC and IRF showed 
recovery. So the True positive patients were 34 (75%). 
In these 34 patients, IRF was early predictor in 24 
(70.5%) cases and ANC in 10 (29.5%) cases. Similarly 
patients who had not shown recovery both by IRF and 
ANC were 4.  The True negative  patients were 
4(8.8%). Patients who  were negative on IRF were 4. 
Total patients positive on ANC were 36 and patients 
who were negative on ANC were 9. Patients showing 
recovery both by IRF and ANC were 34 out of 45. 
 
Table 1.:   Recovery day for IRF and ANC (n=45) 
Recovery day for IRF Recovery day for ANC 
Mean  =   11.7 Mean=17.5 
S.D     =7.1   S.D   =9.3 
p-Value  < 0.002* 
* p = Significant 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1 :  Bone marrow  recovery  by IRF 
 
Discussion 
Patients  of ALL  are more responsive to 
chemotherapy as compared to AML. After 
chemotherapy there is suppression of bone marrow 
activity and patients are prone to infection which can 
further augment marrow suppression. The bone 
marrow recovery after chemotherapy can be assessed 
with the help of parameters like ANC, reticulocyte 
percentage, absolute reticulocyte count (ARC), and 
Immature reticulocyte fraction (IRF). It has been seen 
that IRF  normally constitute about less than 5% of 
total number of reticulocytes. The normal reference 
range for IRF is from 3.0 % - 15.9% in males and 2.3% - 
13.4% in females. During periods of intense 
erythropoietic stimulation they are released into 
peripheral circulation. Different studies have shown 
that an increase in IRF is an early predictor of recovery 
as compared to other parameters after bone marrow 
ablation.8 
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In a study by Briggs et al it has been shown that in 
dyseythropoietic conditions such as acute leukaemias, 
MDS, etc. IRF may be higher at diagnosis, (more than 
the reference range). It drops after chemotherapy. As 
the bone marrow recovers IRF starts rising again. 
Rising IRF is considered a sign of haemopoietic 
recovery.10,11. Our study showed similar trend i-e IRF 
was higher at diagnosis and then gradually dropped 
to a low level after chemotherapy, recovery was 
assessed with the help of rising IRF. 
Studies revealed IRF as a strong indicator of post-
chemotherapy aplasia and also the first sign of 
recovering bone marrow.12 
In a study done by Yesmin et al the mean recovery day 
was 16.6 ±4.6 for IRF and 23.2±6 for ANC.8 In the 
study by Spanish multicentric study group, 
haemopoietic recovery was studied in three groups ,an 
autologous bone marrow transplant group, an 
allogenic bone marrow transplant group and a group 
of patients receiving chemotherapy for acute leukemia. 
It was seen that in all the three groups IRF recovery 
was earlier than ANC and a rising IRF was the first 
sign of recovery. In our study only one group of 
patients was taken and they were being treated with 
chemotherapy. In our study 91% patients had showed 
recovery by IRF and the mean day of bone marrow 
recovery by IRF was 11.7 and that for ANC 17.5. So 
our results are comparable with the results of this 
study.14 
In a study by Kuses et al it was observed that IRF 
fractions like mid-florescence-ratio(MFR) and high-
florescence ratio(HFR) can act as indicators of bone 
marrow recovery. In this study two groups, an acute 
leukaemia and a malignant lymphoma group were 
taken. However in this study IRF fractions were 
compared with absolute reticulocyte count in addition 
to ANC. It was observed that in acute leukaemia 
group MFR showed earlier recovery in comparison 
with ANC. The study showed that mid-flourescence-
ratio. and High-Florescence- -ratio can act as sensitive 
parameters to predict bone marrow recovery.15 
Torres et al also showed that IRF is an earlier predictor 
than absolute neutrophil count in monitoring bone 
marrow recovery. They studied patients who were 
undergoing allogenic and autologous transplant. In 
this study it was observed that there was earlier 
increase in reticulocyte parameters than rise in 
absolute neutrophil count.  
Conclusion 
Immature  Reticulocyte Fraction can predict bone 
marrow recovery. It shows recovery earlier than ANC. 
It can be used as an additional parameter in patients 
who need evaluation of bone marrow recovery after 
chemotherapy.    
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